146 related articles for article (PubMed ID: 2776837)
21. Telenzepine, a new M1-receptor antagonist, is a more potent inhibitor of pentagastrin-stimulated gastric acid output than pirenzepine in dogs.
Holtmann G; Küppers U; Singer MV
Scand J Gastroenterol; 1990 Mar; 25(3):293-7. PubMed ID: 2320949
[TBL] [Abstract][Full Text] [Related]
22. Muscarinic autoreceptors of Torpedo electric organ are of the M1 subtype: evidence by radioligand binding using selective antagonists.
Green AC; Dowdall MJ
J Neurochem; 1992 Feb; 58(2):478-84. PubMed ID: 1729395
[TBL] [Abstract][Full Text] [Related]
23. Influence of the M1-receptor antagonists telenzepine and pirenzepine on pancreatic secretory response to intraduodenal tryptophan in dogs.
Singer MV; Teyssen S; Küppers U
Digestion; 1991; 48(1):34-42. PubMed ID: 1868967
[TBL] [Abstract][Full Text] [Related]
24. Antimuscarinic activity of telenzepine on isolated human urinary bladder: no role for M1-muscarinic receptors.
Poli E; Monica B; Zappia L; Pozzoli C; Bertaccini G
Gen Pharmacol; 1992 Jul; 23(4):659-64. PubMed ID: 1397972
[TBL] [Abstract][Full Text] [Related]
25. Dual synaptic effects of activating M1-muscarinic receptors, in superior cervical ganglia of rabbits.
Mochida S; Mizobe F; Fisher A; Kawanishi G; Kobayashi H
Brain Res; 1988 Jul; 455(1):9-17. PubMed ID: 2458168
[TBL] [Abstract][Full Text] [Related]
26. Selective labelling of muscarinic M1 receptors in calf superior cervical ganglia by [3H](+/-)-telenzepine.
Feifel R; Rodrigues de Miranda JF; Strohmann C; Tacke R; Aasen AJ; Mutschler E; Lambrecht G
Eur J Pharmacol; 1991 Mar; 195(1):115-23. PubMed ID: 2065706
[TBL] [Abstract][Full Text] [Related]
27. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
[TBL] [Abstract][Full Text] [Related]
28. Modulation of M1 and M2 muscarinic receptor subtypes following repeated organophosphate exposure in rats.
Fitzgerald BB; Costa LG
Toxicol Appl Pharmacol; 1992 Nov; 117(1):122-5. PubMed ID: 1440606
[TBL] [Abstract][Full Text] [Related]
29. Differential and selective antagonism of the slow-inhibitory postsynaptic potential and slow-excitatory postsynaptic potential by gallamine and pirenzepine in the superior cervical ganglion of the rabbit.
Ashe JH; Yarosh CA
Neuropharmacology; 1984 Nov; 23(11):1321-9. PubMed ID: 6549348
[TBL] [Abstract][Full Text] [Related]
30. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.
Ehlert FJ; Tran LP
J Pharmacol Exp Ther; 1990 Dec; 255(3):1148-57. PubMed ID: 2262898
[TBL] [Abstract][Full Text] [Related]
31. Gastric antisecretory activity of telenzepine, a new M1-selective muscarinic antagonist: comparison with pirenzepine.
Coruzzi G; Adami M; Bertaccini G
Arch Int Pharmacodyn Ther; 1989; 302():232-41. PubMed ID: 2636819
[TBL] [Abstract][Full Text] [Related]
32. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
[TBL] [Abstract][Full Text] [Related]
33. A pharmacological study of the responses induced by muscarinic agonists on the isolated superior cervical ganglion of the guinea-pig.
Roberts KE; Newberry NR
Eur J Pharmacol; 1990 Sep; 186(2-3):257-65. PubMed ID: 2289527
[TBL] [Abstract][Full Text] [Related]
34. The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.
Hagan JJ; van der Heijden B; Broekkamp CL
Naunyn Schmiedebergs Arch Pharmacol; 1988 Nov; 338(5):476-83. PubMed ID: 3244389
[TBL] [Abstract][Full Text] [Related]
35. Telenzepine-sensitive muscarinic receptors on rat pancreatic acinar cells.
Schmid SW; Modlin IM; Tang LH; Stoch A; Rhee S; Nathanson MH; Scheele GA; Gorelick FS
Am J Physiol; 1998 Apr; 274(4):G734-41. PubMed ID: 9575856
[TBL] [Abstract][Full Text] [Related]
36. Determination of muscarinic agonist potencies at M1 and M2 muscarinic receptors in a modified pithed rat preparation.
Angeli P; Brasili L; Cantalamessa F; Marucci G; Wess J
Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):625-9. PubMed ID: 2096296
[TBL] [Abstract][Full Text] [Related]
37. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses.
Sagrada A; Duranti P; Giudici L; Schiavone A
Life Sci; 1994; 54(17):PL305-10. PubMed ID: 7513038
[TBL] [Abstract][Full Text] [Related]
38. M1 and M3 muscarinic receptor subtypes in rat forebrain.
Pavia J; Marquez E; Laukkonen S; Martos F; Gómez A; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1991 Dec; 13(10):653-60. PubMed ID: 1770828
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of antimuscarinic agents on intestinal motility in the conscious dog.
de Ponti F; Einaudi A; Cosentino M; D'Angelo L; Lecchini S; Frigo GM; Crema A
J Pharmacol Exp Ther; 1993 Feb; 264(2):789-94. PubMed ID: 8437127
[TBL] [Abstract][Full Text] [Related]
40. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
Smith TD; Annis SJ; Ehlert FJ; Leslie FM
J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
